Thank you for signing up to receive information about Aspa’s clinical program for Canavan disease. Periodically you will receive email updates about the natural history study, the progress of company’s gene therapy program, and information about research on Canavan disease and other leukodystrophies that may be of interest to families.

In the meantime, please use the following resources to learn more about Aspa’s clinical program:

• FAQs
• Posters and Presentations